192 related articles for article (PubMed ID: 17493268)
1. Mistletoe lectin is not the only cytotoxic component in fermented preparations of Viscum album from white fir (Abies pectinata).
Eggenschwiler J; von Balthazar L; Stritt B; Pruntsch D; Ramos M; Urech K; Rist L; Simões-Wüst AP; Viviani A
BMC Complement Altern Med; 2007 May; 7():14. PubMed ID: 17493268
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative and anticarcinogenic effects of an aqueous preparation of Abies alba and Viscum album se abies, on a L-1210 malignant cell line and tumor-bearing Wistar rats.
Karkabounas S; Assimakopoulos D; Malamas M; Skaltsounis AL; Leonce S; Zelovitis J; Stefanou D; Evangelou A
Anticancer Res; 2000; 20(6B):4391-5. PubMed ID: 11205277
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of various clinically applied mistletoe preparations on peripheral blood leukocytes.
Elsässer-Beile U; Lusebrink S; Grussenmeyer T; Wetterauer U; Schultze-Seemann W
Arzneimittelforschung; 1998 Dec; 48(12):1185-9. PubMed ID: 9893935
[TBL] [Abstract][Full Text] [Related]
4. Influence of carbohydrates on the cytotoxicity of an aqueous mistletoe drug and of purified mistletoe lectins tested on human T-leukemia cells.
Doser C; Doser M; Hülsen H; Mechelke F
Arzneimittelforschung; 1989 Jun; 39(6):647-51. PubMed ID: 2775329
[TBL] [Abstract][Full Text] [Related]
5. Antitumoral effects of an intravesically applied aqueous mistletoe extract on urinary bladder carcinoma MB49 in mice.
Mengs U; Schwarz T; Bulitta M; Weber K
Anticancer Res; 2000; 20(5B):3565-8. PubMed ID: 11131663
[TBL] [Abstract][Full Text] [Related]
6. [Isolation and characterization of mistletoe extracts (Viscum album L.). II. Effect of agglutinating and cytotoxic fractions on mouse ascites tumor cells].
Luther P; Franz H; Haustein B; Bergmann KC
Acta Biol Med Ger; 1977; 36(1):119-25. PubMed ID: 560094
[TBL] [Abstract][Full Text] [Related]
7. Lack of an antitumoral effect of immunomodulatory galactoside-specific mistletoe lectin on N-methyl-N-nitrosourea-induced urinary bladder carcinogenesis in rats.
Kunze E; Schulz H; Ahrens H; Gabius HJ
Exp Toxicol Pathol; 1997 Aug; 49(3-4):167-80. PubMed ID: 9314050
[TBL] [Abstract][Full Text] [Related]
8. Tolerability of an extract of European mistletoe among immunocompromised and healthy individuals.
Gorter RW; van Wely M; Reif M; Stoss M
Altern Ther Health Med; 1999 Nov; 5(6):37-44, 47-8. PubMed ID: 10550904
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis of endothelial cells by Viscum album: a role for anti-tumoral properties of mistletoe lectins.
Duong Van Huyen JP; Bayry J; Delignat S; Gaston AT; Michel O; Bruneval P; Kazatchkine MD; Nicoletti A; Kaveri SV
Mol Med; 2002 Oct; 8(10):600-6. PubMed ID: 12477970
[TBL] [Abstract][Full Text] [Related]
10. Variable sensitivity of lymphoblastoid cells to apoptosis induced by Viscum album Qu FrF, a therapeutic preparation of mistletoe lectin.
Duong Van Huyen JP; Sooryanarayana ; Delignat S; Bloch MF; Kazatchkine MD; Kaveri SV
Chemotherapy; 2001; 47(5):366-76. PubMed ID: 11561140
[TBL] [Abstract][Full Text] [Related]
11. Generation of reactive oxygen intermediates (ROI) by the thionins from Viscum album L.
Büssing A; Schaller G; Pfüller U
Anticancer Res; 1998; 18(6A):4291-6. PubMed ID: 9891480
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of mistletoe extracts (Viscum album L.). I. Affinity chromatography of mistletoe extracts on immobilized plasma proteins.
Franz H; Haustein B; Luther P; Kuropka U; Kindt A
Acta Biol Med Ger; 1977; 36(1):113-7. PubMed ID: 878740
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory effects of Viscum album agglutinin-I on natural immunity.
Hajto T; Hostanska K; Fischer J; Saller R
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S43-6. PubMed ID: 9179367
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative activity of an aqueous mistletoe extract in human tumor cell lines and xenografts in vitro.
Burger AM; Mengs U; Schüler JB; Fiebig HH
Arzneimittelforschung; 2001 Sep; 51(9):748-57. PubMed ID: 11642008
[TBL] [Abstract][Full Text] [Related]
15. Mistletoe and cancer: controversies and perspectives.
Mansky PJ
Semin Oncol; 2002 Dec; 29(6):589-94. PubMed ID: 12516042
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of phenolic acids in mistletoe plants from various hosts.
Luczkiewicz M; Cisowski W; Kaiser P; Ochocka R; Piotrowski A
Acta Pol Pharm; 2001; 58(5):373-9. PubMed ID: 11876445
[TBL] [Abstract][Full Text] [Related]
17. Interaction of standardized mistletoe (Viscum album) extracts with chemotherapeutic drugs regarding cytostatic and cytotoxic effects in vitro.
Weissenstein U; Kunz M; Urech K; Baumgartner S
BMC Complement Altern Med; 2014 Jan; 14():6. PubMed ID: 24397864
[TBL] [Abstract][Full Text] [Related]
18. Differences in the in vitro effectiveness of preparations produced from mistletoes of various host trees.
Hülsen H; Doser C; Mechelke F
Arzneimittelforschung; 1986 Mar; 36(3):433-6. PubMed ID: 3707661
[TBL] [Abstract][Full Text] [Related]
19. Inability of galactoside-specific mistletoe lectin to inhibit N-methyl-N-nitrosourea-induced tumor development in the urinary bladder of rats and to mediate a local cellular immune response after long-term administration.
Kunze E; Schulz H; Gabius HJ
J Cancer Res Clin Oncol; 1998; 124(2):73-87. PubMed ID: 9654190
[TBL] [Abstract][Full Text] [Related]
20. Characterization of cytotoxic proteins from mistletoe (Viscum album L.).
Jung ML; Baudino S; Ribéreau-Gayon G; Beck JP
Cancer Lett; 1990 May; 51(2):103-8. PubMed ID: 2344587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
